Contact this trialFirst, we need to learn more about you.
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist
Cotadutide for Liver Disease
Recruiting1 awardPhase 1
Canton, Ohio
This trial will study the effects of a new drug, cotadutide, in patients with different levels of liver function. The goal is to see if the drug is safe and effective in these patients.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.